Personalized hearing aid amplification to ameliorate tinnitus

Completed

• Conditions: 10019243; tinnitus

• Registration Number: NL-OMON50937
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 18

Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all
of the following criteria:

- No reported neurological or psychiatric disorders (excluding tinnitus and
hearing loss);
- High frequency hearing loss;
- Moderate- to moderate-severe- degree of hearing loss (PTA of 1, 2 and 4 kHz *
35 dB);
- Chronic tinnitus (lasting more than 6 months);
- Tinnitus percept described as tonal (or at least being able to perceive a
pitch during a tinnitus matching);
- Tinnitus pitch * 8 kHz, and in the hearing loss region;
- Using hearing aids for at least the last 6 months;
- Written informed consent;

Exclusion Criteria

Non-conformance to any of the inclusion criteria stated above;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main parameters to evaluate amelioration of tinnitus are: tinnitus<br /><br>intrusiveness, ability to ignore the tinnitus percept, concentration, quality<br /><br>of sleep and sense of control.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Additionally, the following psychoacoustic measures will take place:<br /><br>- Changes in tinnitus pitch<br /><br>- Changes in tinnitus loudness<br /><br>- Auditory Handicap<br /><br>- Hours of hearing aid use<br /><br><br /><br>Hearing aid benefit and hyperacusis will be assessed by means of<br /><br>questionnaires.</p><br>